Register for MPE´s European Young Myeloma Patients Group webinar on myeloma and physical fitnessMPE, Myeloma, NewsFebruary 5, 2025
The European Commission approves isatuximab + VRd combination therapy for newly diagnosed, transplant ineligible myeloma patientsAccess, Myeloma, NewsJanuary 24, 2025
MPE at ASH 2024: key research and expert insights on myelomaAL amyloidosis, CAR-T, Conferences, MPE, MyelomaDecember 16, 2024
MPE webinar on ASH 2024 myeloma and AL amyloidosis highlightsAL amyloidosis, latest, MPE, Myeloma, NewsNovember 29, 2024
Myeloma and AL amyloidosis ASH 2024 previewAccess, AL amyloidosis, CAR-T, MPE, MyelomaNovember 29, 2024
Denosumab delays the time to first skeletal-related event in patients with myelomaConferences, MyelomaJune 5, 2017
Patients and cancer experts launch a joint vision for improving cancer outcomes in EuropeMyeloma, Patient evidenceJanuary 12, 2017
Addition of daratumumab to bortezomib and dexamethasone in patients with relapsed or refractory shows promising results in a phase III trialMyelomaOctober 13, 2016
Innovative Medicines Initiative (IMI) approves € 40 million project for better care of patients with haematologic malignanciesMyelomaJanuary 9, 2017
